Association of low pregnancy associated plasma protein-A with increased umbilical artery pulsatility index, in cases of fetal weight between the 3rd and 10th percentiles: a retrospective cohort study

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • Carla Maria De Almeida Ramalho

    Autor

Participantes de fora da FMUP

  • da Silva, CD
  • Gon?alves, IS

Unidades de investigação

Abstract

Objectives: This study aims to evaluate if low levels of serum maternal pregnancy associated plasma protein-A (PAPP-A) during the first trimester are related to increased umbilical artery pulsatility index (UA PI) later in pregnancy, in cases of estimated fetal weight between the 3rd and 10th percentiles, in order to establish PAPP-A as a predictor of this particular cases of fetal growth restriction (FGR).Methods: An observational, retrospective cohort study, conducted at a tertiary University Hospital located in Oporto, Portugal. Pregnant women who did the first trimester combined screening, between May 2013 and June 2020 and gave birth in the same hospital, with an estimated fetal weight (EFW) between the 3rd and 10th percentiles were included. The primary outcome is the difference in increased UA PI prevalence between two groups: PAPP-A<0.45 MoM and PAPP-A >= 0.45 MoM. As secondary outcomes were evaluated differences in neonatal weight, gestational age at delivery, cesarean delivery, neonatal intensive care unit hospitalization, 5-min Apgar score below 7 and live birth rate between the same two groups.Results: We included 664 pregnancies: 110 cases of PAPP-A<0.45 MoM and 554 cases with PAPP-A >= 0.45 MoM. Increased UA PI prevalence, which was the primary outcome of this study, was significantly different between the two groups (p=0.005), as the PAPP-A<0.45 MoM group presents a higher prevalence (12.7 %) when compared to the PAPP-A >= 0.45 MoM group (5.4 %). The secondary outcome cesarean delivery rate was significantly different between the groups (p=0.014), as the PAPP-A<0.45 MoM group presents a higher prevalence (42.7 %) than the PAPP-A >= 0.45 MoM group (30.1 %). No other secondary outcomes showed differences between the two groups.Conclusions: There is an association of low serum maternal PAPP-A (<0.45 MoM) during the first trimester and increased UA PI (>95th percentile) later in pregnancy, in cases of EFW between the 3rd and 10th percentiles. However, this association is not strong enough alone for low PAPP-A to be a reliable predictor of increased UA PI in this population.

Dados da publicação

ISSN/ISSNe:
0300-5577, 1619-3997

Journal of Perinatal Medicine  Walter de Gruyter GmbH

Tipo:
Article
Páginas:
90-95

Documentos

  • Não há documentos

Métricas

Filiações

Filiações não disponíveis

Keywords

  • pregnancy associated plasma protein-A; small for gestational age; constitutionally small fetuses; fetal growth restriction; umbilical artery Doppler; Doppler ultrasound

Proyectos asociados

Prenatal diagnosis of fetal skeletal displasias - current state and future perspectives  

Investigador Principal: Carla Maria de Almeida Ramalho

Estudo Clínico Académico ( skeletal displasias) . 2020

Prenatal predictors of prognosis in congenital LUTO

Investigador Principal: Carla Maria de Almeida Ramalho

Estudo Clínico Académico (LUTO) . 2020

Prevalência da colonização por Streptococcus do grupo B nas grávidas do CHUSJ

Investigador Principal: Carla Maria de Almeida Ramalho

Estudo Clínico Académico (Streptococcus B) . 2020

Desfechos neonatais no parto instrumentado: fórceps versus ventosa.

Investigador Principal: Carla Maria de Almeida Ramalho

Estudo Clínico Académico . 2021

The impact of intrapartum ultrasound in the rate of caesarean section

Investigador Principal: Carla Maria de Almeida Ramalho

Estudo Clínico Académico . 2021

Contributions of post-mortem studies in the definition of the etiology of Hydrops Fetalis

Investigador Principal: Carla Maria de Almeida Ramalho

Estudo Clínico Académico . 2022

Desafios nos cuidados após morte fetal: Deverá a via do parto ser uma escolha materna?

Investigador Principal: Carla Maria de Almeida Ramalho

Estudo Clínico Académico . 2020

MATERNAL PREGNANCY-ASSOCIATED PLASMA PROTEIN A AS A MARKER OF FETAL GROWTH RESTRICTION

Investigador Principal: Carla Maria de Almeida Ramalho

Estudo Clínico Académico . 2023

Aborto induzido como problema de saúde no Huambo e uma estratégia para sua redução

Investigador Principal: Carla Maria de Almeida Ramalho

Estudo Clínico Académico . 2022

Citar a publicação

Partilhar a publicação